Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia

Journal of Pain Research

Volumn 5, Issue , 2012, Pages 203-208

  Irving, Gordon A ^a   Sweeney, Michael ^b  

^a Swedish Pain and Headache Center   (United States)

^b Depomed   (United States)

Author keywords

Adverse events; Dizziness; Gabapentin; Gastroretentive; Postherpetic neuralgia; Somnolence

Indexed keywords

GABAPENTIN; PLACEBO;

AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG RETENTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; SOMNOLENCE; TABLET FORMULATION; VITAL SIGN;

EID: 84874984768     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S32562     Document Type: Article

References (19)

1. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996;67:241-251.
2. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New Engl J Med. 2005;352:2271-2284.
3. Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother. 2007;7:1581-1595.
4. Pfizer. Neurontin [package insert]. New York: Pfizer; 2010.
5. Stewart BH, Kugler AR, Thompson PR, Bockbrader HN. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res. 1993;10:276-281.
6. [No authors listed]. Gabapentin extended-release-Depomed: gabapentin ER, gabapentin gastric retention, gabapentin GR. Drugs R D. 2007;8:317-320.
7. Wallace MS, Irving G, Cowles VE. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study. Clin Drug Investig. 2010;30:765-776.
8. Sang CN, Sathyanarayana R, Sweeney M. Once-daily gabapentin (G-GR) reduces intensity of pain associated with post herpetic neuralgia. Clin J Pain. 2012; In press.
9. Rice ASC, Maton S, Group PNS. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215-224.
10. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
11. Johnson P, Becker L, Halpern R, Sweeney T. Dosing patterns, therapy outcomes and health care costs among patients with postherpetic neuralgia (PHN) treated with gabapentin or pregabalin. Pharmacoeconomics. [Submitted.]
12. Cundy KC, Sastry S, Luo W, Zou J, Moors TL, Canafax DM. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin. J Clin Pharmacol. 2008;48:1378-1388.
13. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003;25:81-104.
14. Gordi T, Hou E, Kasichayanula S, Berner B. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive-extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects. Clin Ther. 2008;30:909-916.
15. Chen C, Cowles VE, Hou E. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food. J Clin Pharmacol. 2011;51:346-358.
16. Johnson RW, Wasner G, Saddier P, Baron R. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging. 2008;25:991-1006.
17. Berner B, Cowles VE. Case studies in swelling polymeric gastric retentive tablets. Expert Opin Drug Deliv. 2006;3:541-548.
18. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60:1274-1283.
19. van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin. 2006;22:375-384.